2,5,6-Trichlorobenzimidazole - CAS 16865-11-5
Catalog: |
BB012485 |
Product Name: |
2,5,6-Trichlorobenzimidazole |
CAS: |
16865-11-5 |
Synonyms: |
2,5,6-trichloro-1H-benzimidazole; 2,5,6-trichloro-1H-benzimidazole |
IUPAC Name: | 2,5,6-trichloro-1H-benzimidazole |
Description: | 2,5,6-Trichlorobenzimidazole (CAS# 16865-11-5 ) is a useful research chemical. |
Molecular Weight: | 221.47 |
Molecular Formula: | C7H3Cl3N2 |
Canonical SMILES: | C1=C2C(=CC(=C1Cl)Cl)N=C(N2)Cl |
InChI: | InChI=1S/C7H3Cl3N2/c8-3-1-5-6(2-4(3)9)12-7(10)11-5/h1-2H,(H,11,12) |
InChI Key: | SUQYOUJCBGMSLV-UHFFFAOYSA-N |
Boiling Point: | 399.3 °C at 760 mmHg |
Density: | 1.691 g/cm3 |
MDL: | MFCD09835289 |
LogP: | 3.52310 |
Publication Number | Title | Priority Date |
WO-2020057546-A1 | Cyclic dinucleotide analogue, pharmaceutical composition thereof, and application | 20180921 |
EP-3523314-A1 | Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways | 20161007 |
US-2020040028-A1 | Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways | 20161007 |
WO-2018065360-A1 | Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways | 20161007 |
US-11001605-B2 | Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways | 20161007 |
PMID | Publication Date | Title | Journal |
10772706 | 20000101 | Design, synthesis, and antiviral evaluation of 2-deoxy-D-ribosides of substituted benzimidazoles as potential agents for human cytomegalovirus infections | Nucleosides, nucleotides & nucleic acids |
9575044 | 19980409 | Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles | Journal of medicinal chemistry |
9057865 | 19970227 | Synthesis and antiviral activity of certain 5'-modified analogs of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole | Journal of medicinal chemistry |
9057868 | 19970227 | Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections | Journal of medicinal chemistry |
8632412 | 19960216 | Structure-activity relationships among 2-substituted 5,6-dichloro-, 4,6-dichloro-, and 4,5-dichloro-1-[(2-hydroxyethoxy) methyl]- and -1-[(1,3-dihydroxy-2-propoxy) methyl]benzimidazoles | Journal of medicinal chemistry |
Complexity: | 178 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 219.936181 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 219.936181 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 28.7 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Benzimidazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS